Figure 3From: A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemiaChange from baseline in A) glycoalbumin (%) and B) fasting plasma glucose (mg/dL) over 24Â weeks of treatment with ezetimibe 10Â mg or placebo (PPS).Back to article page